Disease: Neuropsychiatric segment

ARVN		Arvinas, Inc. - Common Stock			-0.41% down 1.93% -2.34		+ Disease: Neuropsychiatric, Medicine, Disease: Oncology	+ My List
ZYNE		Zynerba Pharmaceuticals, Inc. - Common Stock			0		+ Cannabis, Medicine, Pharmaceutical , Disease: Neuropsychiatric	+ My List

We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.